|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jonas S, Thelen A, Benckert C, Spinelli A,
Sammain S, Neumann U, Rudolph B and Neuhaus P: Extended resections
of liver metastases from colorectal cancer. World J Surg.
31:511–521. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pericàs JM, Corredoira J and Miró JM;
Hospital Clínic-Lucus Augusti Working Group for endocarditis:
Colorectal adenomas. N Engl J Med. 375:387–388. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Junttila MR, Puustinen P, Niemelä M, Ahola
R, Arnold H, Böttzauw T, Ala-aho R, Nielsen C, Ivaska J, Taya Y, et
al: CIP2A inhibits PP2A in human malignancies. Cell. 130:51–62.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li W, Ge Z, Liu C, Liu Z, Björkholm M, Jia
J and Xu D: CIP2A is overexpressed in gastric cancer and its
depletion leads to impaired clonogenicity, senescence, or
differentiation of tumor cells. Clin Cancer Res. 14:3722–3728.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ren J, Li W, Yan L, Jiao W, Tian S, Li D,
Tang Y, Gu G, Liu H and Xu Z: Expression of CIP2A in renal cell
carcinomas correlates with tumour invasion, metastasis and
patients' survival. Br J Cancer. 105:1905–1911. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu CY, Shiau CW, Kuo HY, Huang HP, Chen
MH, Tzeng CH and Chen KF: Cancerous inhibitor of protein
phosphatase 2A determines bortezomib-induced apoptosis in leukemia
cells. Haematologica. 98:729–738. 2013. View Article : Google Scholar :
|
|
10
|
Cai F, Zhang L, Xiao X, Duan C, Huang Q,
Fan C, Li J, Liu X, Li S and Liu Y: Cucurbitacin B reverses
multidrug resistance by targeting CIP2A to reactivate protein
phosphatase 2A in MCF-7/adriamycin cells. Oncol Rep. 36:1180–1186.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Perrotti D and Neviani P: Protein
phosphatase 2A: A target for anticancer therapy. Lancet Oncol.
14:e229–e238. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Z, Ma L, Wen ZS, Cheng YX and Zhou GB:
Ethoxysanguinarine induces inhibitory effects and downregulates
CIP2A in lung cancer cells. ACS Med Chem Lett. 5:113–118. 2013.
View Article : Google Scholar
|
|
13
|
Kosina P, Gregorova J, Gruz J, Vacek J,
Kolar M, Vogel M, Roos W, Naumann K, Simanek V and Ulrichova J:
Phytochemical and antimicrobial characterization of Macleaya
cordata herb. Fitoterapia. 81:1006–1012. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ouyang L, Su X, He D, Chen Y, Ma M, Xie Q
and Yao S: A study on separation and extraction of four main
alkaloids in Macleaya cordata (Willd) R. Br. with strip dispersion
hybrid liquid membrane. J Sep Sci. 33:2026–2034. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yao JY, Shen JY, Li XL, Xu Y, Hao GJ, Pan
XY, Wang GX and Yin WL: Effect of sanguinarine from the leaves of
Macleaya cordata against Ichthyophthirius multifiliis in grass carp
(Ctenopharyngodon idella). Parasitol Res. 107:1035–1042. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Konda Y, Urano M, Harigaya Y and Onda M:
Studies on the constituents of bocconia-cordata 0.4. Transformation
of sanguinarine into bocconine. J Heterocycl Chem. 28:1841–1843.
1991. View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
18
|
Cao W, Liu Y, Zhang R, Zhang B, Wang T,
Zhu X, Mei L, Chen H, Zhang H, Ming P, et al: Homoharringtonine
induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal
pathway in Gefitinib-resistant lung cancer cells. Sci Rep.
5:84772015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu X, Duan C, Ji J, Zhang T, Yuan X,
Zhang Y, Ma W, Yang J, Yang L, Jiang Z, et al: Cucurbitacin B
induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1
signaling axis in human cisplatin resistant gastric cancer cells.
Oncol Rep. 38:271–278. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng T, Cao W, Shen W, Zhang L, Gu X, Guo
Y, Tsai HI, Liu X, Li J, Zhang J, et al: Arctigenin inhibits STAT3
and exhibits anticancer potential in human triple-negative breast
cancer therapy. Oncotarget. 8:329–344. 2017.
|
|
21
|
Chou CC, Yang JS, Lu HF, Ip SW, Lo C, Wu
CC, Lin JP, Tang NY, Chung JG, Chou MJ, et al: Quercetin-mediated
cell cycle arrest and apoptosis involving activation of a caspase
cascade through the mitochondrial pathway in human breast cancer
MCF-7 cells. Arch Pharm Res. 33:1181–1191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Y, Dong Y, Zhang B and Cheng YX: Small
compound 6-O-angeloylplenolin induces caspase-dependent apoptosis
in human multiple myeloma cells. Oncol Lett. 6:556–558. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu H, Gu Y, Wang H, Yin J, Zheng G, Zhang
Z, Lu M, Wang C and He Z: Overexpression of PP2A inhibitor SET
oncoprotein is associated with tumor progression and poor prognosis
in human non-small cell lung cancer. Oncotarget. 6:14913–14925.
2015.PubMed/NCBI
|
|
24
|
Rincón R, Cristóbal I, Zazo S, Arpí O,
Menéndez S, Manso R, Lluch A, Eroles P, Rovira A, Albanell J, et
al: PP2A inhibition determines poor outcome and doxorubicin
resistance in early breast cancer and its activation shows
promising therapeutic effects. Oncotarget. 6:4299–4314. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cristóbal I, Zazo S, Torrejón B, Pedregal
M, Madoz-Gúrpide J, Lluch A, Eroles P, Rovira A, Albanell J,
García-Foncillas J, et al: CIP2A confirms its prognostic value in
triple-negative breast cancer. Oncogene. 36:3357–3358. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Balliu M, Cellai C, Lulli M, Laurenzana A,
Torre E, Vannucchi AM and Paoletti F: HDAC1 controls CIP2A
transcription in human colorectal cancer cells. Oncotarget.
7:25862–25871. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang Q, Qin S, Yuan X, Zhang L, Ji J, Liu
X, Ma W, Zhang Y, Liu P, Sun Z, et al: Arctigenin inhibits
triple-negative breast cancers by targeting CIP2A to reactivate
protein phosphatase 2A. Oncol Rep. 38:598–606. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nicholson DW: Caspase structure,
proteolytic substrates, and function during apoptotic cell death.
Cell Death Differ. 6:1028–1042. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Johnstone RW, Ruefli AA and Lowe SW:
Apoptosis: A link between cancer genetics and chemotherapy. Cell.
108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
